We are monitoring the impact of COVID-19 on North America Next Generation Sequencing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 93
Share on
Share on

North America NGS Market Analysis Report – Segmented By Product, Technology, Application and Country (the U.S., Canada, Mexico & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 93
Pages: 145

North American Next Generation Sequencing Market Size (2021 to 2026)

The North American NGS market was worth USD 1.53 billion by the end of 2021 is estimated to reach USD 3.33 billion by 2026, at a CAGR of 16.81% during the forecast period.

The significant factors propelling the growth of the North American NGS market are the increasing incidence of cancer, the increasing applications of NGS in precision medicine, and biomarker discovery. In addition, the rise in the adoption rate of NGS platforms for analysis and diagnostics of rare diseases and for identifying therapeutic targets, the emergence of rapid and advanced sequencing technologies, reduced costs of sequencing, growing demand for NGS methodologies in genomics research, and in clinical diagnosis are further driving the market.

Furthermore, growth in investments in R&D activities due to the high occurrence of cancer and infectious diseases and the development of Next-Generation Sequencing Bioinformatics equipment, and the presence of a significant player in the region drives the market growth. On the other hand, usage of NGS in biomarker detection and precision medicine is likely to positively impact the growth of North America's next-generation sequencing market in the coming years.

The significant challenges restricting the growth of the North American NGS market are Expensive technologies that are not affordable due to budget limitations in developing economies and risks involved with genetic data.

This research report on the North American NGS market has been segmented and sub-segmented into the following categories:

By Product: 

Software

Services

By Technology: 

  • Targeted Re-Sequencing
  • Whole Genome Sequencing
  • De Novo Sequencing
  • Exome Sequencing
  • RNA-Seq
  • ChIP-Seq
  • Methyl-Seq

By Application: 

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture
  • Animals Research

By Country: 

  • The United States
  • Canada
  • Mexico
  • Rest of North America

Regionally, the U.S. NGS Market dominates the NGS market in North America and is expected to maintain the trend during the forecast period due to rapid developments in healthcare, particularly in the biotechnology field. Canada is displaying significant growth in recent years. It is likely to grow consistently during the forecast period owing to the research advancements and rising adoption of NGS products in hospitals and clinics. 

The United States Next-Generation Sequencing market contains all sequencing services directed with next-generation or third-generation platforms that use newer technology than old capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation, and NGS-based sequencing run with primary data output. The increasing number of Next Generation Sequencing new research activities in Canadian universities is leading to the growth of the Next Generation Sequencing data analysis market in this region.

KEY MARKET PLAYERS:

Companies playing a leading role in the North American NGS Market profiled in this report are Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc., Partek Inc., Genomatix Software GmbH, Perkin Elmer Inc., GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd., DNASTAR Inc., Knome Inc., and Qiagen N.V.

  1. Introduction

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

  1. Research Methodology

                2.1 Introduction               

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

  1. Overview

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

  1. Market Segmentation

                5.1 By Product  

                                5.1.1 Software

                                5.1.2 Services

                5.2 By Technology           

                                5.2.1 Whole Targeted Re-Sequencing

                                5.2.2 Genome Sequencing

                                5.2.3 De Novo Sequencing

                                5.2.4 Exome Sequencing

                                5.2.5 RNA-Seq

                                5.2.6 ChIP-Seq

                                5.2.7 Methyl-Seq

                5.3 By Application           

                                5.3.1 Diagnostics

                                5.3.2 Drug Discovery

                                5.3.3 Biomarker Discovery

                                5.3.4 Personalized Medicine

                                5.3.5 Agriculture and Animals Research

  1. Geographical Analysis

                6.1 Introduction               

                6.2 United States            

                6.3 Canada         

  1. Strategic Analysis

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

  1. Market Leaders' Analysis

                8.1 Macrogen Inc.           

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Thermo Fischer Scientific      

                8.3 Life Sciences (Roche)             

                8.4 Pacific Biosciences   

                8.5 Life Technologies Corp.         

                8.6 Partek Inc.  

                8.7 Genomatix Software GmbH

                8.8 Perkin Elmer Inc.      

                8.9 GATC Biotech Ag      

                8.10 Agilent Technologies Inc.   

                8.11 Biomatters Ltd.       

                8.12 CLC Bio (Qiagen)    

                8.13 Pacific Biosciences 

  1. Competitive Landscape

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

  1. Expert Opinions

                10.1 Market Outlook     

                10.2 Investment Opportunities 

     Appendix                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America NGS Market By Region, From 2021 to 2026 (USD Billion)
  2. North America NGS Market By Product, From 2021 to 2026 (USD Billion)
  3. North America Software Market By Region, From 2021 to 2026 (USD Billion)
  4. North America Services Market By Region, From 2021 to 2026 (USD Billion)
  5. North America NGS Market By Technology, From 2021 to 2026 (USD Billion)
  6. North America Whole Targeted Re-Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  7. North America Genome Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  8. North America De Novo Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  9. North America Exome Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  10. North America RNA-Seq Market By Region, From 2021 to 2026 (USD Billion)
  11. North America ChIP-Seq Market By Region, From 2021 to 2026 (USD Billion)
  12. North America Methyl-Seq Market By Region, From 2021 to 2026 (USD Billion)
  13. North America NGS Market By Application, From 2021 to 2026 (USD Billion)
  14. North America Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  15. North America Drug Discovery Market By Region, From 2021 to 2026 (USD Billion)
  16. North America Biomarker Discovery Market By Region, From 2021 to 2026 (USD Billion)
  17. North America Personalized Medicine Market By Region, From 2021 to 2026 (USD Billion)
  18. North America Agriculture and Animals Research Market By Region, From 2021 to 2026 (USD Billion)
  19. United States NGS Market By Product, From 2021 to 2026 (USD Billion)
  20. United States NGS Market By Technology, From 2021 to 2026 (USD Billion)
  21. United States NGS Market By Application, From 2021 to 2026 (USD Billion)
  22. Canada NGS Market By Product, From 2021 to 2026 (USD Billion)
  23. Canada NGS Market By Technology, From 2021 to 2026 (USD Billion)
  24. Canada NGS Market By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample